Gemcitabine HCl Market Growth Outlook: North America Leads as Asia Pacific Accelerates
The global gemcitabine HCl market is expected to witness strong growth through 2031, supported by the increasing prevalence of cancer and growing demand for effective chemotherapy treatments. Valued at approximately US$ 635.1 million in 2021, the market is projected to expand at a CAGR of 7.8% from 2022 to 2031, reaching more than US$ 1.3 billion by 2031. Rising Cancer Cases Fuel Market...
0 Commentaires 0 Parts 7 Vue 0 Aperçu